IL17A and systemic lupus erythematosus: In agreement with previously published literature, increased IL-17 is also observed in systemic lupus erythematosus(SLE) (30), rheumatoid arthritis (RA) (31)and diabetes (32) and may contribute to oral microbial alterations in these diseases.